ICRP Publication 103 — The 2007 Recommendations of the International Commission on Radiological Protection

Table of Contents

1. Source documents

  • Publication 103 PDF retained locally — ICRP, 2007; supplied 17 September 2026.
  • Extracted text
  • Provenance and SHA-256 metadata
  • Official ICRP publication page — citation, abstract and publisher download.

2. Authority and jurisdiction

  • International recommendations and professional consensus issued by the ICRP, an independent advisory body.
  • Publication 103 is not legislation and does not directly regulate THHS. Its concepts influence IAEA standards and Australian frameworks; legal or local force requires an identified Queensland, licence or approved-plan mechanism.
  • ICRP is reviewing the system with a view to new general recommendations around 2030. Publication 103 remains the current general recommendations until superseded, while later ICRP publications may update particular topics.

3. Key takeaways

  • Defines three principles of radiological protection—justification, optimisation and application of dose limits—and specifies where each applies. Justification and optimisation apply across planned, emergency and existing exposure situations; dose limits apply to occupational and public exposure from regulated sources in planned situations, not to patients' intended medical exposure.
  • Makes optimisation central and uses prospective dose or risk constraints for planned exposure and reference levels for emergency and existing exposure; these tools are not interchangeable with dose limits.
  • Distinguishes exposure situations (planned, emergency and existing) from exposure categories (occupational, public and medical), preventing controls for one category from being transferred uncritically to another.
  • Defines effective dose as a reference-person protection quantity for planning, optimisation and compliance; it is not an individual-specific cancer-risk estimate, a tissue-reaction quantity or a substitute for patient organ/tissue dose.
  • For medical exposure, protection depends on layered justification and optimisation, competent professionals, dosimetry, quality assurance and accident prevention rather than limiting the prescribed therapeutic dose.
  • Provides the conceptual international layer beneath IAEA GSR Part 3 and Australian sources; Queensland law, licence conditions and the approved RSPP remain the immediate authorities for THHS practice.

4. Summary

4.1. 1 — Introduction

  • Describes the history and development of the Commission's recommendations and the structure of Publication 103.
  • Consolidates the 1990 recommendations and later guidance while updating biological, dosimetric and system concepts.

4.2. 2 — Aims and scope

  • Sets the system's aims: contribute to protection of people and the environment without unduly limiting beneficial activities; manage tissue-reaction and stochastic risks.
  • Applies in full where a source or exposure pathway can reasonably be controlled, with exclusion and exemption used to define practical regulatory scope.

4.3. 3 — Biological aspects of radiological protection

  • Summarises tissue reactions, stochastic effects, diseases other than cancer, embryo/fetus effects, and the judgements and uncertainties used for protection decisions.
  • Uses population evidence and prudent models to support protection; it does not turn a protection coefficient into a precise prediction for an identified individual.

4.4. 4 — Quantities used in radiological protection

  • Distinguishes physical, protection and operational quantities and updates radiation and tissue weighting factors.
  • Defines equivalent and effective dose using reference models and sex-averaged tissue weighting factors.
  • Limits effective dose to population-based protection uses. Individual risk or tissue-reaction assessment requires appropriate organ/tissue absorbed doses and case-specific biological information.
  • Collective effective dose supports optimisation only when the exposed population, dose range and time period are specified; aggregating trivial individual doses over very large populations or times is inappropriate for risk projection.

4.5. 5 — The system of radiological protection of humans

  • Defines a source for protection decisions and separates planned, emergency and existing exposure situations.
  • Separates occupational, public and patient medical exposure, while addressing carers, comforters and research volunteers where relevant.
  • States the three principles and distinguishes source-related constraints/reference levels from individual-related dose limits.
  • Treats justification as achieving more good than harm and optimisation as the best protection under prevailing circumstances, below the applicable restriction.

4.6. 6 — Implementation of the recommendations

  • Applies the system to planned, emergency and existing exposure situations, including normal and potential exposures.
  • For planned exposure, integrates design, construction, operation, maintenance, decommissioning, waste and foreseeable deviations; occupational and public protection use optimisation and dose limitation.
  • For emergency and existing exposure, protection strategies are optimised prospectively using reference levels, followed by evaluation and further improvement.
  • Assigns national authorities the regulatory role and users of sources responsibility for practical protection arrangements; domestic law determines the enforceable duties.

4.7. 7 — Medical exposure

  • Uses three levels of justification: the general use of radiation in medicine, a defined procedure for a stated objective, and the procedure for the individual patient.
  • Optimises the intended medical exposure for the clinical purpose; diagnostic reference levels can support imaging optimisation but are not individual patient limits.
  • Emphasises training, normal-tissue dose awareness and prevention of accidental exposure in external-beam radiotherapy and brachytherapy.
  • Addresses pregnancy, carers and comforters, and volunteers in biomedical research separately because their benefit and protection relationships differ from those of the treated patient.

4.8. 8 — Protection of the environment

  • Introduces an explicit framework using Reference Animals and Plants to assess environmental protection.
  • Does not propose environmental dose limits in Publication 103.

4.9. Annex A — Biological and epidemiological information

  • Documents the health-risk evidence, risk models, nominal risk coefficients, detriment calculations and associated judgements supporting the recommendations.

4.10. Annex B — Quantities used in radiological protection

  • Gives the physical and computational basis for dosimetric quantities, reference models, weighting factors and assessment methods.

5. Important definitions, roles, limits and records

Planned exposure situation
Deliberate introduction and operation of a source; includes anticipated normal exposure and foreseeable potential exposure.
Emergency exposure situation
Unexpected situation requiring urgent action to avoid or reduce undesirable consequences.
Existing exposure situation
Exposure already present when a decision about control is required, including prolonged post-emergency exposure.
Dose constraint
Prospective source-related restriction used in optimisation for planned exposure; it is not a dose limit.
Reference level
Prospective restriction for emergency or existing exposure above which allowing exposure is judged inappropriate and below which optimisation continues.
Effective dose
Reference-person protection quantity, suitable principally for prospective planning/optimisation and demonstrating compliance, not for estimating a named patient's or worker's individual health risk.
Dose limits
ICRP recommends limits for occupational and public exposure in planned situations; they do not apply to the patient's intended medical exposure. Use current Queensland legislation—not Publication 103 alone—to state binding THHS limits.
Roles and records
Publication 103 describes responsibilities at a general level but does not define THHS office holders, detailed record systems or retention periods. Those come from IAEA/Australian requirements, Queensland instruments, licence conditions and the approved RSPP.

6. Practical relationship to the THHS RSPP

  • Supplies the concepts used to distinguish patient, worker and public protection and to organise justification, optimisation, limitation, constraints, reference levels and foreseeable potential exposures.
  • Supports radiotherapy controls for prescription and justification, normal-tissue optimisation, calibrated delivery, QA, independent verification, maintenance, incident prevention and learning.
  • The traceability route is normally ICRP → IAEA and Australian sources → Queensland law/licence conditions → approved RSPP → procedures and records; Publication 103 is not treated as a direct legal instruction to THHS.
  • Later source-specific requirements and current Queensland/local instruments prevail where they are more specific or have been updated.

7. See Also